SS

Suman Singh

Active Director Director DIN 08846045
DIN 08846045 First appointment Aug 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Suman Singh

Data last updated:

Suman Singh is a Director at Neogenix Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Neogenix Pharmaceuticals Private Limited reported revenue of ₹33.5 Lakh (FY 2023).

DIN 08846045
Primary Designation Director
Industry Healthcare
First Appointment 24 Aug 2020
Oldest Company Age 10 yrs
Largest company Neogenix Pharmaceuticals Private Limited · ₹33.5 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20202016₹33.5 Lakh (FY 2023)Active

Board colleagues of Suman Singh

NameDINCompanyDesignation
Ankita Srivastva07431842Neogenix Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neogenix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suman Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suman Singh

Suman Singh currently holds 1 directorship: Neogenix Pharmaceuticals Private Limited (Director, since 24 Aug 2020, revenue ₹33.5 Lakh (FY 2023)).

Suman Singh was first appointed on 24 Aug 2020 as Director at Neogenix Pharmaceuticals Private Limited.

The current boards of Suman Singh's companies include Ankita Srivastva (Neogenix Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available